CLU and cancer: Within this network, we find a specific role for HSF1 as the transcriptional regulator of Clu. Using cancer organoids, co-cultures, and in-vivo models we show that HSF1 mediates a transcriptional shift of PSCs into CLU+ CAFs which exert immune regulatory characteristics (Fig. 6n).